Protagonist Therapeutics, Inc. PTGX stock jumped 42.84% after the company announced topline results from its Phase 2b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results